Kelly, Mann receive 2026 Canada Gairdner International Award
Jeffery W. Kelly and Matthias Mann have been named recipients of the 2026 Canada Gairdner International Award for their contributions to biomedical science. Kelly is recognized for his work on protein misfolding and amyloid diseases, while Mann is honored for his pioneering developments in proteomics and mass spectrometry.
Why it matters
These awards highlight critical advancements in understanding protein-related diseases like Alzheimer's and ALS, which are essential for developing future therapeutic strategies.
Jeffery W. Kelly and Matthias Mann have been named recipients of the 2026 Canada Gairdner International Award. The award recognizes scientists whose seminal discoveries and research contributions have advanced biomedical science and improved human health.
Presented annually by the Gairdner Foundation, the Canada Gairdner International Award recognizes researchers whose work has had a profound impact on biology and medicine.
Kelly is a professor of chemistry at Scripps Research Institute in La Jolla, California. He received the Canada Gairdner International Award for discovering tafamidis to ameliorate transthyretin amyloidosis, the first effective treatment for an amyloid disease and for demonstrating that stabilizing proteins can prevent disease-causing aggregation.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in